Skip to content

SOFTWAVE THERAPY FOR ULCERS

Let Healing Begin with SoftWave

softwave-device

SoftWave therapy is a non-invasive treatment that uses patented technology to promote healing at the cellular level, improve blood supply, and initiate the body’s natural healing process.

  • Improves blood supply and reduces inflammation
  • Patented and FDA(510k) cleared
  • 10-15 minute treatment sessions
  • Fast acting with long term results
  • No downtime, anesthesia, or numbing agents needed
softwave-device

Treat Ulcers with An Affordable Alternative to Surgery, Injections, or Medication

Join the thousands of patients who have experienced life-changing relief from SoftWave Therapy.

Treating Ulcers With SoftWave Therapy

Ulcers are open sores or lesions that develop on the skin or mucous membranes, often as a result of tissue damage or impaired blood circulation. They can be painful and are prone to infection if not properly treated.

Softwave_BackPain_600x400-1

Ulcers are open sores or lesions that develop on the skin or mucous membranes, often as a result of tissue damage or impaired blood circulation. They can be painful and are prone to infection if not properly treated.

SoftWave can be an effective treatment solution for ulcers. Additionally, SoftWave is clinically proven with a 61% to 91% improvement in musculoskeletal and general pain complaints. It has helped thousands of patients get real lasting relief.
Softwave_BackPain_600x400-1

Regrettably, ulcers affect more than 2.5 million people in the United States. Common symptoms of ulcers include:

  • Open, painful sores or lesions on the skin or mucous membranes.
  • Redness, inflammation, or swelling around the ulcer site.
  • Drainage or pus coming from the ulcer.
  • Pain or discomfort at the site, especially when touched or pressed.
  • Slower healing of the ulcer and a tendency to recur if not properly managed.

Common causes of ulcers include bacterial or viral infections, poor circulation, prolonged pressure on specific areas, and underlying conditions like diabetes or autoimmune disorders.

SoftWave providers can develop a plan for treating ulcers. With our $69 New Patient Special, you can try SoftWave today and learn if you’re a candidate for treatment.

Andrew

"I'm better on pivoting because there is weakness in my left leg, so I can pivot a lot better.  Struggling with spinal stenosis and neuropathy in her feet, Karen experienced burning numbness and was scheduled for surgery. But, she decided to try SoftWave Therapy as an alternative. After her first session, she had better movement.

Sara

"You wanna see me walking? I don't limp anymore. I haven't had a limp since after the first treatment" Sara has had her foot pain stop her from walking, exercising, and doing the things she loves. A week after SoftWave therapy, she experienced significant relief. 

Alton

"At this point, I have not had any burning at all, I've been able to sleep through the night, and I'm walking straight. Other than that, I'm not feeling any pain. Totally sleeping better. I don't have any sensation now during my sleeping hours."  From feeling like he was walking on shards of glass to experiencing a significant improvement in walking, Alton now sleeps without pain thanks to SoftWave therapy.

Shock Wave Therapy for Acute and Chronic Soft Tissue Wounds

This study investigated the feasibility and safety of using extracorporeal shock wave therapy (ESWT) for complicated, nonhealing, acute and chronic soft-tissue wounds. Two hundred and eight patients were enrolled, with treatment consisting of debridement, outpatient ESWT, and moist dressings. Of the 208 patients, 156 had 100% wound epithelialization during a mean follow-up period of 44 days, and there were no treatment-related toxicities, infections, or deterioration of any ESWT-treated wound. The study concluded that ESWT is a feasible and well-tolerated strategy for treating acute and chronic soft tissue wounds.

Extracorporeal Shockwave Treatment for Chronic Diabetic Foot Ulcers

In a study comparing extracorporeal shockwave treatment (ESWT) with hyperbaric oxygen therapy (HBO) for chronic diabetic foot ulcers, 72 patients were divided into ESWT and HBO groups. ESWT resulted in complete healing in 31%, improvement in 58%, and no change in 11% of cases, while HBO showed 22% complete healing, 50% improvement, and 28% no change. The ESWT group exhibited better clinical outcomes, blood flow, cell concentration, and activity compared to HBO. Immunohistochemical analysis revealed increased expressions of certain proteins related to wound healing in the ESWT group. In conclusion, ESWT shows greater efficacy in treating chronic diabetic foot ulcers than HBO.

Shockwave Therapy Reduces Wound Size by 99.9% in Elderly Patients

Alternative therapy using DermaGold soft-focused Multiwave treatment was administered to an 80-year-old patient with a large infected decubitus ulcer, resulting in a 99.9% decrease in wound size, significant healing, and nearly scar-free healthy skin tissue regeneration, demonstrating the potential of shockwave therapy as a non-invasive, pain-free option for chronic wound treatment.

New Patient Special

Try SoftWave Therapy for $69 at a clinic near you.

SoftWave FAQs

  • What is SoftWave therapy?
  • Where can I go to get SoftWave therapy?
  • What is the SoftWave treatment process like?
  • What results should I expect from SoftWave therapy?
  • Is SoftWave FDA-cleared?
  • Does SoftWave therapy have side effects?